Skip to main content
Clinical Trials/NCT06418893
NCT06418893RecruitingPhase 2

Effect of Isoflurane and Target Control Infusion (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients: A Randomized Controlled Trial.

Institute of Liver and Biliary Sciences, India1 site in 1 country60 target enrollmentStarted: August 1, 2023Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
Comparison of total Noradrenaline and vasopressin requirement between isoflurane and TCI propofol group in Living donor liver transplant recipients intraoperatively.

Study Overview

Brief Summary

Both isoflurane and propofol are being used to give anaesthesia for living donor liver transplant in our institute. Propofol when compared to isoflurane has advantages like early awakening from anaesthesia, reduced nausea, vomiting in the postoperative period. Propofol also has antioxidant properties. Because of its antioxidant properties propofol may have a protective effect against oxidative stress and ischemia reperfusion injury in major organs during liver transplant surgery. However, there are no studies showing the effect of isoflurane and propofol on Intraoperative hemodynamics and postoperative liver and kidney functions.Thus, we are conducting this study to know the effect of these agents on intraoperative hemodynamics and postoperative liver and kidney function.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Above 18 years of age who will undergo living donor liver transplant

Exclusion Criteria

  • Refusal to consent
  • Acute liver failure, Acute on chronic liver failure
  • Allergic to propofol or any component of propofol
  • Patients with pre existing cardiac dysfunction and cardiomyopathy
  • Patients with pre existing renal dysfunction/ deranged RFTs preoperatively

Arms & Interventions

Isoflurane

Active Comparator

Drug- Isoflurane Dosage form- Inhalational, 1-2% Frequency- Continuously Duration- Throughout Intraoperative period

Intervention: Inhalational isoflurane (Drug)

Propofol

Experimental

Drug- Propofol Dosage form- Intravenously, 2.5 mcg/ml target plasma concentration Frequency- Continuously Duration- Throughout Intraoperative period

Intervention: Target control infusion propofol (Drug)

Outcomes

Primary Outcomes

Comparison of total Noradrenaline and vasopressin requirement between isoflurane and TCI propofol group in Living donor liver transplant recipients intraoperatively.

Time Frame: INTRAOPERATIVELY

TCI propofol will provide more stable hemodynamics

Secondary Outcomes

  • To compare between the two groups cardiac output during different phases of liver transplant recorded every 15 minutes(INTRAOPERATIVELY AT 15 MINUTES INTERVAL)
  • Peak dose of nordrenaline and vasopressin during different phases of liver transplant intraoperatively(Intraoperatively)
  • Postoperative Liver function tests ie Bilirubin and albumin(at 12, 24, 72 hours and day 7 postoperatively)
  • Total vasopressor requirement during reperfusion(Intraoperative)
  • Postoperative Liver function tests ie GGT(at 12, 24, 72 hours and day 7 postoperatively)
  • Postoperative Liver function tests ie platelet count(at 12, 24, 72 hours and day 7 postoperatively)
  • To compare between the two groups mean systemic vascular resistance during different phases of liver transplant recorded every 15 minutes(INTRAOPERATIVELY AT 15 MINUTES INTERVAL)
  • QTc interval between the two groups during different phases of liver transplant measured every 15 minutes(Intraoperatively every 15 mins)
  • Postoperative coagulation profile(at 12, 24, 72 hours and day 7 postoperatively)
  • To compare between the two groups mean arterial pressure during different phases of liver transplant recorded every 15 minutes(INTRAOPERATIVELY AT 15 MINUTES INTERVAL)
  • Postoperative Liver function tests ie AST and ALT(at 12, 24, 72 hours and day 7 postoperatively)
  • Postoperative Renal function tests i.e. Blood urea and S.creatinine levels(at12, 24, 72 hours and day7 postoperatively)
  • Peak lactate levels intraoperatively(Intraoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials